Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
NCT01336894 trial: what clinicians have said so far
Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer
- NCT01336894 ↗
- Terminated
- Alliance for Clinical Trials in Oncology
- Focused size, estimated: 1–150 verified statements once built
We haven't built an HCP commentary report on NCT01336894 (high-risk stage I non-small cell lung cancer; tests a strategy, not a drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT01336894 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 3 posts on X, typically up to 13 once built |
The trial
ClinicalTrials.gov- Official title
- A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) Versus Stereotactic Body Radiation Therapy in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC)
- Phase
- Phase 3
- Status
- Terminated
- Conditions
- Lung Cancer
- Interventions
- therapeutic conventional surgery; iodine I 125; stereotactic body radiation therapy
- Arms
- Arm I (SR+Brachytherapy) · Active comparator
- Arm II (SBRT) · Experimental
- Enrollment
- 13
- Primary outcomes
- 3-year Overall Survival (OS) Rate
- Sponsor
- Alliance for Clinical Trials in Oncology with National Cancer Institute (NCI)
- Start
- May 2011
- Primary completion
- May 2013
- Results posted
- Yes
- Registry record
- NCT01336894 · updated May 30, 2017
Publications
linked from the registry- Fernando HC, Timmerman R. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012 Sep;144(3):S35-8. doi: 10.1016/j.jtcvs.2012.06.003. Epub 2012 Jul 11. PubMed 22795435